Numab
Series CNumab raised €53M in a Series C round in Jan 2025. The company is based in Wadenswil, Switzerland. Investors in the round: Cormorant Asset Management, Forbion, HBM Healthcare Investments and 1 other. Data as of Nov 2026.
Amount raised
€53M
€53,372,149
Native amount
55,000,000 USD
Stage
Series C
series c
Investors
4
Provenance & confidence
High confidenceAmount
55,000,000 USD
ECB-at-date → €53M · rate 1.0305 on 2025-01-09
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
4 namedDate
Jan 2025
Round type
series c
Amount (EUR)
€53M